Alexandra Perez, PharmD, MBA, BCGP

Who Is Alexandra Perez, PharmD, MBA, BCGP?

Dr. Alexandra Perez is a licensed pharmacist and Board Certified Geriatric Pharmacist who specializes in chronic disease state management. Public professional biographies describe her experience working with healthcare providers in primary care settings to review and optimize medication regimens, particularly for older adults and people managing multiple long-term conditions.

Her work has also included clinical informatics and collaboration with pharmaceutical organizations using real-world clinical data for research. This places her career at the intersection of direct patient care and population-level analysis. In practical terms, she has experience thinking about both the person sitting in an examination room and the patterns hidden inside thousands of health records.

Perez has also served as a medical content reviewer for major health information platforms. Her reviewed material has covered prescription medications, side effects, interactions, treatment costs, Medicare topics, chronic diseases, reproductive safety, and other issues that require careful clinical interpretation.

Education and Professional Credentials

Doctor of Pharmacy

Perez earned her Doctor of Pharmacy degree from the University of Florida. A PharmD is the professional doctoral degree that prepares pharmacists to evaluate drug therapy, identify medication-related problems, counsel patients, collaborate with other clinicians, and support the safe use of prescription and nonprescription products.

The training involves much more than memorizing medication names that appear to have been invented during an unusually competitive spelling contest. Pharmacists study pharmacology, therapeutics, patient assessment, disease management, drug interactions, health systems, calculations, ethics, and evidence-based decision-making.

Master of Business Administration

She later completed an MBA at the University of Florida. Business training can be highly relevant in pharmacy because treatment decisions occur within complicated systems involving insurance coverage, formularies, resource allocation, quality measurement, patient access, organizational strategy, and healthcare economics.

Combining a PharmD with an MBA can help a professional translate clinical value into operational language. A recommendation may be medically excellent, but it must also be implementable. Someone must understand staffing, budgeting, data measurement, stakeholder communication, and the uncomfortable reality that even brilliant plans can collapse under a badly designed workflow.

Biological Sciences Foundation

Perez earned a Bachelor of Science degree from the University of Miami. A biology background provides preparation in scientific reasoning, experimental design, cellular processes, physiology, and the interpretation of research. Those skills create a useful foundation for advanced pharmacy education and clinical analysis.

Board Certified Geriatric Pharmacist

The BCGP designation identifies Perez as a Board Certified Geriatric Pharmacist. According to the Board of Pharmacy Specialties, this certification is intended for pharmacists with advanced knowledge and experience in assessing, designing, implementing, monitoring, and modifying medication therapy for older adults.

Geriatric pharmacotherapy demands specialized judgment because aging can affect kidney function, liver function, body composition, cognition, balance, medication sensitivity, and the ability to follow a complicated treatment schedule. A dose or combination that appears routine on paper may require substantial adjustment when viewed in the context of frailty, fall risk, memory changes, caregiver support, or multiple chronic illnesses.

A Focus on Geriatric Pharmacy and Chronic Disease Management

Perez’s professional focus on geriatric pharmacy is particularly important because older adults frequently receive medications from several prescribers. One clinician may treat diabetes, another may manage heart disease, and a third may address pain or sleep. Meanwhile, the patient may also use vitamins, herbal products, over-the-counter pain relievers, and a mystery tablet kept in an unlabeled kitchen drawer since approximately the invention of Wi-Fi.

The pharmacist’s job is not simply to count the number of prescriptions. It is to determine whether each medication still has a clear purpose, whether the doses remain appropriate, whether one treatment is worsening another condition, and whether the overall regimen matches the patient’s priorities.

Medication Regimen Optimization

Medication optimization involves reviewing benefits, risks, duplication, interactions, adherence barriers, monitoring requirements, and treatment goals. A pharmacist may recommend changing a dose, selecting an alternative drug, simplifying a schedule, improving monitoring, or discussing whether a medication can be reduced or discontinued.

This process is especially relevant for people with diabetes, chronic obstructive pulmonary disease, heart failure, high blood pressure, high cholesterol, depression, and other conditions that may require long-term treatment. The goal is not automatically to prescribe more or less. The goal is to use the right therapy for the right person at the right time.

Understanding Polypharmacy

Polypharmacy generally refers to the use of multiple medications, although the clinical concern is not merely the total number. Five necessary, well-monitored medications may be appropriate, while two poorly matched drugs may create a serious problem.

Geriatric pharmacists evaluate whether the expected benefit of each medication outweighs its potential burden. That burden can include dizziness, confusion, low blood pressure, bleeding, low blood sugar, constipation, sedation, falls, financial stress, or an administration schedule so complicated that it practically requires air-traffic control.

Collaboration in Primary Care

Public biographies describe Perez as having worked alongside healthcare providers in primary care clinics. This collaborative model allows pharmacists to contribute medication expertise while physicians, nurses, care managers, and other professionals address diagnosis, preventive care, lifestyle factors, and broader treatment planning.

A primary care pharmacist may examine laboratory values, refill patterns, blood pressure readings, blood glucose results, adverse effects, insurance restrictions, and patient preferences. The pharmacist can then provide evidence-based recommendations to the care team.

Consider an older adult who takes medications for diabetes, hypertension, heart failure, arthritis, and insomnia. The patient reports fatigue and dizziness but cannot identify which treatment may be responsible. A structured review may reveal overlapping blood pressure effects, a dose that no longer matches kidney function, or a sedating medicine being taken at the wrong time. Solving the problem requires clinical knowledge, careful questioning, and communication across the care team.

Clinical Informatics and Real-World Evidence

Another significant part of Perez’s background is clinical informatics and the use of real-world clinical data. Clinical informatics connects healthcare knowledge with information systems, electronic records, analytical methods, and decision-support tools.

The U.S. Food and Drug Administration describes real-world data as information routinely collected about patient health or healthcare delivery. Sources may include electronic health records, insurance claims, disease registries, and other clinical databases. When researchers analyze these data to study the use, benefits, or risks of medical products, the resulting findings may be considered real-world evidence.

Traditional clinical trials remain essential, but they cannot answer every question. Trial participants may differ from the patients eventually treated in everyday practice. Real-world analysis can help researchers examine how therapies perform among older adults, people with multiple illnesses, patients taking several medications, and populations that may have been underrepresented in controlled studies.

Why Clinical Interpretation Still Matters

Large datasets can produce impressive charts, but a chart is not automatically a clinically useful answer. Health records may contain missing information, coding errors, inconsistent follow-up, treatment-selection bias, or incomplete details about why a clinician made a particular decision.

A pharmacist with clinical and analytical experience can help determine whether a pattern is medically plausible, whether important variables have been overlooked, and whether the conclusions are meaningful for actual patient care. Data can tell researchers what happened. Clinical expertise helps explain what it might mean.

Health Economics, Value, and Outcomes

Perez’s broader professional experience has been associated with health economics, data consulting, medical affairs, and value-and-outcomes work. These disciplines examine not only whether a treatment works, but also how it affects quality of life, healthcare utilization, patient access, clinical outcomes, and total cost.

A medication with a higher purchase price may reduce hospitalizations or complications. A less expensive treatment may still create poor value if patients cannot tolerate it or consistently stop taking it. Conversely, a highly effective therapy offers limited real-world benefit when insurance barriers, administration requirements, or out-of-pocket costs prevent patients from obtaining it.

This is where the PharmD and MBA combination becomes particularly useful. Clinical evidence, patient outcomes, business strategy, and access considerations are not separate planets. In healthcare, they orbit the same increasingly complicated sun.

Medical Content Review and Public Health Communication

Perez has been listed as a medical reviewer across Healthline, Medical News Today, Greatist, and Healthgrades. Medical reviewers help evaluate whether consumer health content accurately explains medication uses, side effects, warnings, interactions, administration, costs, and situations in which a reader should contact a healthcare professional.

Her review portfolio has included information about common drugs as well as specialty medications used in oncology, neurology, immunology, infectious disease, and rare conditions. It has also included Medicare coverage, medication affordability, pregnancy and breastfeeding considerations, prior authorization, and chronic disease treatment.

Reviewing public-facing health information requires a different style of expertise from writing a clinical note. The content must be accurate without becoming unreadable, useful without becoming personalized medical advice, and appropriately cautious without making every paragraph sound like a pharmaceutical commercial’s final 12 seconds.

Why Pharmacist Review Matters

Medication articles can cause harm when they oversimplify risks, omit important precautions, confuse brand and generic products, or suggest that readers change treatment without professional guidance. Pharmacist reviewers help identify these problems before publication.

They may verify whether a side effect is common or rare, whether an interaction is clinically meaningful, whether monitoring is recommended, and whether the wording appropriately reflects approved prescribing information and current evidence.

Teaching, Mentorship, and Professional Leadership

Public profiles also describe Perez as holding a pharmacist teaching certificate, participating on a pharmaceutical industry advisory board, teaching pharmacy technician courses, and guest lecturing at the University of Florida and the University of South Florida colleges of pharmacy.

Teaching strengthens healthcare practice because instructors must organize complex knowledge, explain their reasoning, answer unexpected questions, and recognize where learners are likely to become confused. A pharmacist who teaches must be able to move between technical precision and practical communication.

Perez has also been associated with professional organizations including the Academy of Managed Care Pharmacy, the American Society of Consultant Pharmacists, the American Society of Health-System Pharmacists, and Phi Lambda Sigma. These affiliations reflect interests in managed care, senior care, health-system practice, leadership, and professional development.

What Makes Alexandra Perez’s Career Path Distinctive?

The most notable feature of Perez’s career is not one job title or credential. It is the way several disciplines connect.

Geriatric pharmacy offers a patient-centered understanding of medication complexity. Primary care experience supports collaboration with prescribers. Clinical informatics adds the ability to analyze healthcare information. Health economics broadens the discussion to value and access. Business education helps turn ideas into workable strategies. Medical review translates technical evidence for the public.

Together, these skills support a full medication lifecycle perspective: how a therapy is studied, evaluated, selected, covered, prescribed, monitored, explained, and experienced by patients.

Experience-Based Lessons Related to Alexandra Perez’s Work

The following observations are analytical examples based on the professional settings associated with Perez’s career. They are not private stories, personal quotations, or claims about individual patients.

The Medication List Is Only the Beginning

In geriatric care, a printed medication list rarely tells the full story. A patient may skip an expensive drug, divide tablets without telling the prescriber, borrow a spouse’s pain reliever, or take an old prescription only when symptoms become severe. Supplements and nonprescription products may never appear in the electronic record.

An experienced medication review therefore begins with conversation rather than assumption. The useful question is not simply, “What has been prescribed?” It is, “What are you actually taking, when are you taking it, and what happens afterward?” That distinction can uncover adherence problems, adverse effects, confusion, and unnecessary therapy.

Simplification Can Be a Clinical Intervention

A technically perfect treatment plan can fail when it is too complicated to follow. Multiple daily administration times, special food instructions, injections, inhalers, monitoring requirements, and refill schedules can overwhelm patients and caregivers.

Simplifying a regimen may involve aligning administration times, using combination products when appropriate, eliminating duplication, improving packaging, or selecting a treatment that better matches the patient’s routine. These changes may appear administrative, but they can directly influence safety and outcomes.

Deprescribing Requires More Than Deleting a Prescription

Reducing unnecessary medication use is not the same as casually telling a patient to stop treatment. Some drugs require gradual dose reduction. Others may be controlling symptoms that return when the medicine is withdrawn. Patients may also feel anxious about discontinuing something they have taken for years.

A thoughtful deprescribing process identifies the original indication, evaluates current benefits and risks, creates a monitoring plan, and involves the patient and prescriber. The objective is not to win a contest for the shortest medication list. It is to reduce avoidable harm while preserving effective care.

Data Need a Human Interpreter

Real-world databases can reveal patterns across large populations, but those patterns require context. A high discontinuation rate might indicate adverse effects, poor effectiveness, insurance changes, treatment completion, or incomplete data. A lower healthcare cost might represent efficient careor reduced access.

Professionals with both clinical and analytical experience are valuable because they can challenge attractive but misleading conclusions. They ask whether the comparison groups are truly comparable, whether the measured outcome matters to patients, and whether the database captures the information needed to support the claim.

Communication Is Part of Medication Safety

A medication recommendation does not help when the patient cannot understand it. Instructions such as “take twice daily” may be interpreted differently by different people. Terms such as contraindication, titration, immunosuppression, or bioavailability may be routine to clinicians but meaningless to many readers.

Clear communication means explaining what the medicine is for, how to use it, what to expect, which warning signs require help, and what should not be changed without professional advice. It also means checking understanding instead of asking the famously unreliable question, “Do you understand?”

Business Knowledge Can Support Better Care

Healthcare professionals sometimes treat business concepts as though they are unrelated to patient care. In reality, staffing models, budgets, insurance rules, operational design, and performance measures shape whether clinical services survive.

A pharmacist may identify an excellent medication-management program, but decision-makers will still ask how many patients it can serve, how outcomes will be measured, what technology it requires, and whether it reduces avoidable costs. Business literacy allows clinicians to answer those questions without abandoning the patient-centered purpose of the program.

Public Medical Education Requires Restraint

Online health content must help readers recognize important issues without encouraging self-diagnosis or unsupervised treatment changes. That balance is difficult. Overly vague advice is useless, while overly specific instructions may be unsafe for people whose medical histories are unknown.

The strongest consumer medication content explains general principles, identifies urgent warning signs, and encourages appropriate discussion with a qualified professional. It informs the reader without pretending that a webpage has reviewed laboratory results, allergies, kidney function, insurance coverage, and the contents of the bathroom medicine cabinet.

Conclusion

Alexandra Perez, PharmD, MBA, BCGP, has built a professional profile that reflects the expanding role of pharmacists in American healthcare. Her background combines geriatric pharmacotherapy, chronic disease management, primary care collaboration, clinical informatics, real-world evidence, health economics, teaching, and medical content review.

This multidisciplinary experience is especially relevant as medication therapy becomes more specialized and patient care becomes more data-driven. Older adults and people with chronic conditions need professionals who can evaluate complicated regimens, communicate with clinical teams, interpret evidence, consider affordability, and explain health information clearly.

Perez’s career illustrates that pharmacy is not limited to dispensing medications. It can involve improving treatment systems, studying outcomes, educating future professionals, reviewing public health information, and helping ensure that medication decisions make sense in the real worldnot merely in a spreadsheet or textbook.